Skip to main content
. 2022 Aug 12;13(1):204–212. doi: 10.1016/j.apsb.2022.08.003

Figure 2.

Figure 2

Cell toxicity evaluation of APAP and APAP analogues. (A) Viability of human HepG2 cell lines after treatment with APAP or tag-derivatized APAP analogues. (B) Viability of mouse liver cells after treatment with APAP or APAP analogues.